Overview

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia

Status:
Not yet recruiting

Trial end date:
2024-11-18

Target enrollment:

Participant gender:

Summary

This study is a single-center propsective clinical trial to assess the ability of fluorescence techniques to mark high-grade vulvar intraepithelial neoplasias including high-grade vulvar squamous intraepithelial lesions and differentiated vulvar intraepithelial neoplasias following 3 hours Metvixia application.

Phase:

Phase 2

Details

Lead Sponsor:

Institut de Cancérologie de Lorraine

Treatments:

Methyl 5-aminolevulinate